Which client care outcome is appropriate for monitoring a client receiving a continuous heparin infusion?

Monitoring a client receiving a continuous heparin infusion primarily involves ensuring their safety with regard to bleeding complications. Heparin is an anticoagulant medication used to prevent blood clots, and one of the significant risks associated with its use is bleeding. Petechiae and purpura are signs that indicate the presence of superficial bleeding or a bleeding disorder, which can arise from anticoagulant therapy.

By ensuring that the client remains free of petechiae or purpura, healthcare providers can assess that the heparin dosage is appropriate and that the client is not experiencing adverse effects related to excessive anticoagulation. This outcome is essential in evaluating the effectiveness of the heparin therapy while minimizing the risk of hemorrhage.

In contrast, the other options represent concerning symptoms or outcomes that would not be appropriate indicators for monitoring a client on heparin. A heart rate exceeding 100 beats per minute could indicate tachycardia, which may occur for various reasons and does not directly relate to the effects of heparin. Severe chest pain at rest would suggest a serious condition requiring immediate attention, such as a possible cardiac event, which is unrelated to the effects of heparin. Muscle cramping in the extremities might be indicative of